MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, 510631, China.
William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Biomaterials. 2018 Nov;183:20-29. doi: 10.1016/j.biomaterials.2018.08.038. Epub 2018 Aug 21.
Detection of specific extracellular RNAs has been developed for non-invasive cancer diagnosis. However, accurate and efficient identification of RNAs with single-point mutation in cancer cells-derived extracellular vesicles (EVs) is challenging. Herein, we present a unique overhang molecular beacon with internal dye (Ohi-MB) with a stable hairpin structure, fast hybridization kinetics and single mismatch specificity. Ohi-MBs are encapsulated in cationic lipoplex nanoparticles (CLNs) that are tethered on a gold coated glass slide as a chip, which can capture circulating EVs and detect encapsulated target RNAs in-situ in a single step. The capability of detection of single-point mutation by CLN-Ohi-MB is demonstrated in artificial EVs and cancer cells. This CLN-Ohi-MB biochip could quantify single-point mutations in KRAS mRNA (G12C, G12D, G12V) in pancreatic cancer cell-derived EVs and single-point mutations in EGFR mRNA (L858R and T790M) in lung cancer cell-derived EVs with high specificity, not achievable by conventional molecular probes. We show that CLN-Ohi-MB biochip could selectively and sensitively identify single-point mutations in KRAS mRNA in human serum EVs, distinguishing pancreatic cancer patients with different mutations.
已经开发出用于非侵入性癌症诊断的特定细胞外 RNA 检测方法。然而,准确高效地识别癌细胞来源的细胞外囊泡(EVs)中的单点突变 RNA 具有挑战性。在此,我们提出了一种独特的带有内部染料的悬垂分子信标(Ohi-MB),具有稳定的发夹结构、快速的杂交动力学和单错配特异性。Ohi-MB 被包裹在阳离子脂质体纳米颗粒(CLN)中,这些纳米颗粒被连接在涂有金的玻璃片上作为芯片,可以捕获循环的 EVs,并在单个步骤中就地检测包裹的靶 RNA。CLN-Ohi-MB 检测单点突变的能力在人工 EVs 和癌细胞中得到了证明。这种 CLN-Ohi-MB 生物芯片可以定量检测胰腺癌细胞衍生的 EVs 中 KRAS mRNA(G12C、G12D、G12V)和肺癌细胞衍生的 EVs 中 EGFR mRNA(L858R 和 T790M)中的单点突变,具有常规分子探针无法实现的高特异性。我们表明,CLN-Ohi-MB 生物芯片可以选择性和灵敏地识别人血清 EVs 中 KRAS mRNA 的单点突变,区分具有不同突变的胰腺癌患者。